Overview
- The former Titans running back disclosed his diagnosis on Good Morning America on Monday and used an eye‑triggered speech‑generating device programmed with recordings of his voice to speak.
- Johnson says symptoms began in 2025 with weakness in his right hand and that the disease has progressed quickly enough to take his natural voice and much of his motor function.
- He is receiving standard ALS care involving multiple approved medications and has joined a clinical trial led by Dr. Merit Cudkowicz at Mass General Brigham that she says may have provided benefit.
- The Tennessee Titans and former teammates issued public support and Johnson said his family and children are his main motivation for sharing his story and continuing treatment.
- ALS has no cure and typical survival after symptom onset is variable so Johnson’s disclosure could raise public attention, drive fundraising, and speed interest in research and earlier diagnosis efforts.